Details of the Drug

General Information of Drug (ID: DME2W98)

• Drug Name: SGX301

Indication

Disease Entry	ICD 11	Status	REF
Cutaneous T-cell lymphoma	2B01	Phase 3	[1]

• Cross-matching ID:
  PubChem CID: 3663
  TTD ID: D0NC9E

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)